PharmaLex Denmark A/S — Credit Rating and Financial Key Figures

PharmaLex Denmark A/S (CVR number: 18652439) is a company from LYNGBY-TAARBÆK. The company recorded a gross profit of 17.2 mDKK in 2025. The operating profit was -2166.5 kDKK, while net earnings were -1712.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -13.6 %, which can be considered poor and Return on Equity (ROE) was -39.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 15.1 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. PharmaLex Denmark A/S's liquidity measured by quick ratio was 2.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.